Small pancreatic neuroendocrine tumors

Prospective nationwide observational cohort of patient with pancreatic neuroendocrine tumors <2cm.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON22819

Enrollment

100

Registered

2017-09-06

Start date

2017-01-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic neuroendocrine tumors Neuroendocriene tumoren van de alvleesklier

Interventions

No interventions, since patients will be treated according to the international 2016 ENETS guidelines.

Eligibility

Inclusion criteria

Inclusion criteria: - Diagnosed with pancreatic NET on at least 2 imaging modalities (pathology is not necessary, only in doubt) - No distant metastases - Patients >18 years - Able to read and write in Dutch/English

Exclusion criteria

Exclusion criteria: - Hereditary syndromes - Functioning pNET (insulinoma, gastrinoma etc) - pNET grade 3 according to 2010/2017 WHO grading system

Design outcomes

Primary

Measure	Time frame
Tumor progression	—

Secondary

Measure	Time frame
Surgical resection rate Reasons to resect Quality of Life Survival	—

Contacts

Public ContactE.J.M Nieveen van Dijkum

Department of Surgery Academic Medical Center Amsterdam

e.j.nieveenvandijkum@amc.nl

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)